OBJECTIVE: To describe the content and frequency of communication about health-related quality of life (HRQOL) during outpatient encounters between oncologists and their patients with advanced cancer. METHODS: We coded for HRQOL talk in a subset of audio-recorded conversations (each previously found to contain prognostic talk by the oncologist) from the Study of Communication in Oncologist-Patient Encounters Trial, a randomized controlled trial conducted from 2003 to 2008 in two large US academic medical centers and one Veterans Affairs Medical Center. RESULTS:Seventy-three encounters involved 70 patients and 37 oncologists. Patients were more likely to be female (53%), White (86%), married (78%), and possessing some college education (62%). Most oncologists were male (78%) and White (78%). Mean ages were 59 years for patients and 44 years for oncologists. Every encounter included some talk about HRQOL and HRQOL discussions made up, on average, 25% of the visit time. HRQOL segments described symptoms (50%), general HRQOL (27%), and the following concerns: physical (27%), functional (22%), psychological (9%), social (7%), spiritual (1%), and other (28%). Topics included treatment (56%), disease (14%), and testing (3%), and conversations focused on past (44%), present (68%), and future HRQOL (59%). CONCLUSIONS: HRQOL discussions between oncologists and patients are common, but the emphasis is often on treatment (e.g. side effects) and symptoms (e.g. pain) even in patients with advanced disease. Given the often intense emotional experience of patients with advanced cancer, oncologists may need to pay more attention to psychological, social, and spiritual HRQOL concerns. Copyright 2009 John Wiley & Sons, Ltd.
RCT Entities:
OBJECTIVE: To describe the content and frequency of communication about health-related quality of life (HRQOL) during outpatient encounters between oncologists and their patients with advanced cancer. METHODS: We coded for HRQOL talk in a subset of audio-recorded conversations (each previously found to contain prognostic talk by the oncologist) from the Study of Communication in Oncologist-Patient Encounters Trial, a randomized controlled trial conducted from 2003 to 2008 in two large US academic medical centers and one Veterans Affairs Medical Center. RESULTS: Seventy-three encounters involved 70 patients and 37 oncologists. Patients were more likely to be female (53%), White (86%), married (78%), and possessing some college education (62%). Most oncologists were male (78%) and White (78%). Mean ages were 59 years for patients and 44 years for oncologists. Every encounter included some talk about HRQOL and HRQOL discussions made up, on average, 25% of the visit time. HRQOL segments described symptoms (50%), general HRQOL (27%), and the following concerns: physical (27%), functional (22%), psychological (9%), social (7%), spiritual (1%), and other (28%). Topics included treatment (56%), disease (14%), and testing (3%), and conversations focused on past (44%), present (68%), and future HRQOL (59%). CONCLUSIONS: HRQOL discussions between oncologists and patients are common, but the emphasis is often on treatment (e.g. side effects) and symptoms (e.g. pain) even in patients with advanced disease. Given the often intense emotional experience of patients with advanced cancer, oncologists may need to pay more attention to psychological, social, and spiritual HRQOL concerns. Copyright 2009 John Wiley & Sons, Ltd.
Authors: Celine M Koropchak; Kathryn I Pollak; Robert M Arnold; Stewart C Alexander; Celette Sugg Skinner; Maren K Olsen; Amy S Jeffreys; Keri L Rodriguez; Amy P Abernethy; James A Tulsky Journal: Palliat Med Date: 2006-12 Impact factor: 4.762
Authors: Lisa M Wintner; Johannes M Giesinger; Georg Kemmler; Monika Sztankay; Anne Oberguggenberger; Eva-Maria Gamper; Barbara Sperner-Unterweger; Bernhard Holzner Journal: Wien Klin Wochenschr Date: 2012-04-27 Impact factor: 1.704
Authors: Keri L Rodriguez; Nichole K Bayliss; Stewart C Alexander; Amy S Jeffreys; Maren K Olsen; Kathryn I Pollak; Sarah K Garrigues; James A Tulsky; Robert M Arnold Journal: Psychooncology Date: 2010-08-25 Impact factor: 3.894
Authors: R García-Carbonero; R Vera; F Rivera; E Parlorio; M Pagés; E González-Flores; C Fernández-Martos; M Á Corral; R Bouzas; F Matute Journal: Clin Transl Oncol Date: 2016-05-20 Impact factor: 3.405
Authors: Neeraj K Arora; Roxanne E Jensen; Nadiyah Sulayman; Ann S Hamilton; Arnold L Potosky Journal: J Clin Oncol Date: 2013-09-23 Impact factor: 44.544
Authors: Anna P B M Braeken; Gertrudis I J M Kempen; Daniëlle Eekers; Francis C J M van Gils; Ruud M A Houben; Lilian Lechner Journal: BMC Cancer Date: 2011-11-08 Impact factor: 4.430